Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...

While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide Decanoate, the other is Merck's cancer therapy Sacituzumab Tirumotecan.

On December 17, the US Food and Drug Administration moved to fast-track reviews of two experimental Merck & Co., Inc.

The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at prioritizing medicines that ...

Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...

The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers working on products that could cure chronic disease, prepare for a pandemic ...

The U.S. Food and Drug Administration (FDA) is reportedly set to launch a pilot program to fast-track the review of nicotine pouches from four major tobacco companies amid mounting pressure from the ...

The MarketWatch News Department was not involved in the creation of this content. Solarsuns investment Guild, under the strategic guidance of founder Maverick Preston, has introduced a fast-track ...

The General Services Administration (GSA) Headquarters building. (SAUL LOEB/AFP via Getty Images) Anthropic and OpenAI, two of the country’s leading AI companies, recently announced that they’re ...

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review ...